Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age55+

SponsorMayo Clinic

About this trial

This study evaluates if AI can be used with transvaginal ultrasound images for early detection of endometrial cancer or premalignant lesions.

Age ≥ 55 years

At least one episode of postmenopausal bleeding (PMB)

Endometrial biopsy available from at Mayo Clinic (MN, AZ, FL), Mayo Clinic Health System (MCHS), or an external institution

Acceptance to participate in the study

Diagnostic tests performed more than 90 days apart

Physical impediment/refusal to undergo transvaginal ultrasound (TVUS)

300 Participants

are divided into 1 treatment group

Mayo Clinic

Lead sponsor